» Articles » PMID: 9148432

[The Therapeutic Management of Radiogenic Oral Mucositis]

Overview
Specialties Oncology
Radiology
Date 1997 Apr 1
PMID 9148432
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute reactions of oral mucosa are a frequent side effect of radiotherapy, which often necessitates interruption of the treatment. Marked proliferation of tumor stem cells during treatment interruptions may occur in squamous cell carcinomata, which represent the majority of tumors in the head and neck area. Hence a fatal consequence of treatment breaks may be a significant decrease in tumor cure rates. Furthermore, marked acute responses frequently result in increased late sequelae ("consequential damage"). Therefore, amelioration of the mucosal response aiming at avoiding treatment breaks and at reduction of late reactions could definitely increase the therapeutic success of radiation treatment.

Patients And Method: Various possibilities for the therapeutic management of radiation-induced oral mucositis with a symptomatic or radio- and epithelial biological background are summarized and presented systematically.

Results: A variety of prophylactic and therapeutic methods have been proposed for the management of acute radiation reactions of the oral mucosa. Frequently, their efficacy has been established for chemotherapy or in combination with other immunosuppressive treatments. Hence, systematical rather than local effects have to be considered.

Conclusions: In general, prophylaxis of oral mucositis is mainly based on dental restoration or edentation, in combination with frequent oral hygienic measures after the meals and with antiseptic mouthwashes. Intensive personal care is recommended. The necessity of a percutaneous endoscopic gastrostoma is dependent on the status of the patient and on size and localization of the treatment area, i.e. the impairment of food uptake which is to be expected. Therapeutic intervention is restricted to local or systemic treatment of pain and local application of antimycotics and antibiotics.

Citing Articles

Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation.

Schmidt M, Haagen J, Noack R, Siegemund A, Gabriel P, Dorr W Strahlenther Onkol. 2014; 190(4):399-404.

PMID: 24452815 DOI: 10.1007/s00066-013-0510-3.


Prospective study of the long term change of the oral flora after radiation therapy.

Al-Nawas B, Grotz K Support Care Cancer. 2005; 14(3):291-6.

PMID: 16341728 DOI: 10.1007/s00520-005-0895-3.


Long-term oral Candida colonization, mucositis and salivary function after head and neck radiotherapy.

Grotz K, Genitsariotis S, Vehling D, Al-Nawas B Support Care Cancer. 2003; 11(11):717-21.

PMID: 12910407 DOI: 10.1007/s00520-003-0506-0.


The effect of keratinocyte growth factor on healing of manifest radiation ulcers in mouse tongue epithelium.

Dorr W, Spekl K, Farrell C Cell Prolif. 2002; 35 Suppl 1:86-92.

PMID: 12139711 PMC: 6496397. DOI: 10.1046/j.1365-2184.35.s1.9.x.


[Prevention and therapy of acute radiation-related morbidity of the skin and mucosa. II, Recommendations of the literature].

Zimmermann J, Niehoff P, Wilhelm R, Schneider R, Kovacs G, Kimmig B Strahlenther Onkol. 1998; 174(4):193-9.

PMID: 9581179 DOI: 10.1007/BF03038526.


References
1.
Wang R, Boyle A . A convenient method for guarding against localized mucositis during radiation therapy. J Prosthodont. 1994; 3(4):198-201. DOI: 10.1111/j.1532-849x.1994.tb00155.x. View

2.
Rutkauskas J, Davis J . Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report. Oral Surg Oral Med Oral Pathol. 1993; 76(4):441-8. DOI: 10.1016/0030-4220(93)90010-2. View

3.
Kim J, Chu F, Lakshmi V, Houde R . Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx. Am J Clin Oncol. 1986; 9(2):132-4. DOI: 10.1097/00000421-198604000-00006. View

4.
Ciais G, Namer M, Schneider M, Demard F, POURREAU-SCHNEIDER N, Martin P . [Laser therapy in the prevention and treatment of mucositis caused by anticancer chemotherapy]. Bull Cancer. 1992; 79(2):183-91. View

5.
Overgaard J, Johansen L, Andersen A . Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol. 1988; 27(2):147-52. DOI: 10.3109/02841868809090334. View